Logo

Industry Consortium Wins $2.5M from German Government to Develop Adenoviral siRNA Kinome Chip

Jun 17, 2005

NEW YORK, June 17 (GenomeWeb News) - ProQinase, the NMI Natural and Medical Sciences Institute, and Antibodies by Design, all based in Germany, have received a three-year, €2 million ($2.45 million) grant from the German government to develop an adenoviral siRNA kinome chip, the partners said today.

 

The chip will enable scientists to inhibit all human protein kinases in parallel by RNA interference.

 

Under the collaboration, Antibodies by Design, a division of Munich-based MorphoSys, will generate recombinant antibodies against up to 250 protein kinases. NMI, a non-profit contractor based at the Universityof T bingen, together with MorphoSys, will create shRNA vectors. ProQinase, a division of KTB Tumorforschungs GmbH at the TumorBiologyCenterin Freiburg, will use the antibodies to confirm deactivation of the protein kinases by the shRNA vectors. NMI will also combine all the components into a chip format.

 

NMI said it has filed for a patent protecting the production and use of the chip with the German Patent Office.

Breaking News
The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.